A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replication

Gastroenterology

Volumn 144, Issue 7, 2013, Pages

  Fusco, Dahlene N ^a   Brisac, Cynthia ^a   John, Sinu P ^b,i   Huang, Yi Wen ^c   Chin, Christopher R ^d,i   Xie, Tiao ^e   Zhao, Hong ^f   Jilg, Nikolaus ^a   Zhang, Leiliang ^g   Chevaliez, Stephane ^a,h   Wambua, Daniel ^a   Lin, Wenyu ^a   Peng, Lee ^a   Chung, Raymond T ^a   Brass, Abraham L ^d,i  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f PEKING UNIVERSITY FIRST HOSPITAL   (China)

^g PEKING UNION MEDICAL COLLEGE   (China)

^h HENRI MONDOR HOSPITAL   (France)

ⁱ Ragon Institute   (United States)

Author keywords

Gene Regulation; Mechanism; Treatment; Virology

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE DEAMINASE COMPLEXING PROTEIN 2; ALPHA 1,2 GLUCOSYLTRANSFERASE; ALPHA INTERFERON; ASPARAGINE; CHOLINESTERASE; DIPEPTIDYL PEPTIDASE IV; FATTY ACID TRANSPORTER; GLUCOKINASE; GLUCOSYLTRANSFERASE; GUANYLATE CYCLASE; GUANYLATE CYCLASE 1; HEPATITIS C CORE ANTIBODY; HISTONE ACETYLTRANSFERASE; MYST HISTONE ACETYLTRANSFERASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 3; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ARTICLE; CONTROLLED STUDY; DENGUE VIRUS; FLAVIVIRUS; GENE EXPRESSION; GENETIC SCREENING; GENETIC TRANSFECTION; GLYCOSYLATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 84878279903     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.02.026     Document Type: Article

References (30)

1. R.R. Razonable Antiviral drugs for viruses other than human immunodeficiency virus Mayo Clin Proc 86 2011 1009 1026
2. P. Leyssen, E. De Clercq, J. Neyts Molecular strategies to inhibit the replication of RNA viruses Antiviral Res 78 2008 9 25
3. E. De Clercq Ten paths to the discovery of antivirally active nucleoside and nucleotide analogues Nucleosides Nucleotides Nucleic Acids 31 2012 339 352
4. A. Isaacs, J. Lindenmann Virus interference I. The interferon Proc R Soc Lond B Biol Sci 147 1957 258 267
5. J.W. Schoggins, S.J. Wilson, M. Panis A diverse range of gene products are effectors of the type I interferon antiviral response Nature 472 2011 481 485
6. P. Metz, E. Dazert, A. Ruggieri Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication Hepatology 56 2012 2082 2093
7. S.Y. Liu, D.J. Sanchez, R. Aliyari Systematic identification of type I and type II interferon-induced antiviral factors Proc Natl Acad Sci U S A 109 2012 4239 4244
8. S.Y. Liu, R. Aliyari, K. Chikere Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol Immunity 38 2013 92 105
9. Q. Li, A.L. Brass, A. Ng A genome-wide genetic screen for host factors required for hepatitis C virus propagation Proc Natl Acad Sci U S A 106 2009 16410 16415
10. C.J. Echeverri, P.A. Beachy, B. Baum Minimizing the risk of reporting false positives in large-scale RNAi screens Nat Methods 3 2006 777 779
11. H. Zhao, W. Lin, K. Kumthip A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus J Hepatol 56 2012 326 333
12. B.P. Fairfax, S. Makino, J. Radhakrishnan Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles Nat Genet 44 2012 502 510
13. C. Zhao, C. Denison, J.M. Huibregtse Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways Proc Natl Acad Sci U S A 102 2005 10200 10205
14. B. Bartosch, J. Dubuisson, F.L. Cosset Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes J Exp Med 197 2003 633 642
15. M. Sarasin-Filipowicz, E.J. Oakeley, F.H. Duong Interferon signaling and treatment outcome in chronic hepatitis C Proc Natl Acad Sci U S A 105 2008 7034 7039
16. J.J. Feld, S. Nanda, Y. Huang Hepatic gene expression during treatment with peginterferon and ribavirin: identifying molecular pathways for treatment response Hepatology 46 2007 1548 1563
17. X.S. He, S. Nanda, X. Ji Differential transcriptional responses to interferon-alpha and interferon-gamma in primary human hepatocytes J Interferon Cytokine Res 30 2010 311 320
18. R.E. Lanford, B. Guerra, H. Lee Genomic response to interferon-alpha in chimpanzees: implications of rapid downregulation for hepatitis C kinetics Hepatology 43 2006 961 972
19. X.S. He, X. Ji, M.B. Hale Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race Hepatology 44 2006 352 359
20. U. Garaigorta, M.H. Heim, B. Boyd Hepatitis C virus (HCV) induces formation of stress granules whose proteins regulate HCV RNA replication and virus assembly and egress J Virol 86 2012 11043 11056
21. R. Sumpter Jr, Y.M. Loo, E. Foy Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I J Virol 79 2005 2689 2699
22. J.E. Darnell Jr, I.M. Kerr, G.R. Stark Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 264 1994 1415 1421
23. J.W. Schoggins, C.M. Rice Interferon-stimulated genes and their antiviral effector functions Curr Opin Virol 1 2011 519 525
24. R.I. Dmitriev, M.I. Shakhparonov, N.B. Pestov Structure and function of MYST1 histone acetyltransferase in the interactome of animal cells Biochemistry (Mosc) 73 2008 839 852
25. J. Reichenbach, R. Schubert, J. Feinberg Impaired interferon-gamma production in response to live bacteria and Toll-like receptor agonists in patients with ataxia telangiectasia Clin Exp Immunol 146 2006 381 389
26. T. Tomaru, T. Satoh, S. Yoshino Isolation and characterization of a transcriptional cofactor and its novel isoform that bind the deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma Endocrinology 147 2006 377 388
27. S. Surapureddi, S. Yu, H. Bu Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator Proc Natl Acad Sci U S A 99 2002 11836 11841
28. A. Antonelli, S.M. Ferrari, C. Mancusi Interferon-alpha, -beta and -gamma induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor gamma agonists Immunobiology 2012 Aug 9 [Epub ahead of print]
29. L. Alvarez Mde, A.D. Quiroga, J.P. Parody Cross-talk between IFN-alpha and TGF-beta1 signaling pathways in preneoplastic rat liver Growth Factors 27 2009 1 11
30. M. Basu, R.K. Maitra, Y. Xiang, X. Meng, A.K. Banerjee, S. Bose Inhibition of vesicular stomatitis virus infection in epithelial cells by alpha interferon-induced soluble secreted proteins J Gen Virol 87 2006 2653 2662